At a time when we face greatest risk for pandemics, market incentives dissuade pharmaceutical investment in the development of vaccines. As Sen. Bernie Sanders promises to “end… pharmaceutical industry greed,” the coronavirus rages. But Sanders isn’t quite right. The problem isn’t greed, it is the forces that drive pharmaceutical companies to innovate.
